29 results
6-K
EX-10.2
ACIU
AC Immune SA
4 Aug 21
Current report (foreign)
7:21am
6-K
EX-10.3
ACIU
AC Immune SA
4 Aug 21
Current report (foreign)
7:21am
6-K
EX-10.1
ACIU
AC Immune SA
4 Aug 21
Current report (foreign)
7:21am
6-K
EX-10.1
ACIU
AC Immune SA
23 Mar 20
AC Immune Receives Second Milestone and New Milestone to Increase the Potential Deal Value of Lilly Morphomerâ„¢ Tau Partnership
8:15am
6-K
EX-10.1
ACIU
AC Immune SA
20 Sep 19
AC Immune Receives First Milestone Payment from Lilly in Small Molecule Tau Morphomerâ„¢ Program
7:53am
F-1/A
EX-10.5
mnye gds6l3s
13 Sep 16
Registration statement (foreign) (amended)
12:00am
F-1/A
EX-10.3
mxxya pvuayils7kb7g
13 Sep 16
Registration statement (foreign) (amended)
12:00am
F-1
EX-10.1
u0ffnay zob432
31 May 16
Registration statement (foreign)
12:00am
F-1
EX-10.4
i6v 84tp3j
31 May 16
Registration statement (foreign)
12:00am
F-1
EX-10.9
yiy wi4jtrwex
31 May 16
Registration statement (foreign)
12:00am
F-1
EX-10.7
81449tb9c276m
31 May 16
Registration statement (foreign)
12:00am
F-1
EX-10.5
ljiv4y4isq2kg
31 May 16
Registration statement (foreign)
12:00am
F-1
EX-10.6
f70udb9
31 May 16
Registration statement (foreign)
12:00am
F-1
EX-10.2
7oq0f8fb
31 May 16
Registration statement (foreign)
12:00am
F-1
EX-10.3
8ry8r5pwz xc5m1
31 May 16
Registration statement (foreign)
12:00am
F-1
EX-10.8
17zsxxh4
31 May 16
Registration statement (foreign)
12:00am
DRS/A
EX-10.5
0hqlia1t k8
24 Nov 15
Draft registration statement (amended)
12:00am
DRS/A
EX-10.9
nb7uo 6agodxro2n
24 Nov 15
Draft registration statement (amended)
12:00am
DRS/A
EX-10.8
oui71f
24 Nov 15
Draft registration statement (amended)
12:00am
DRS/A
EX-10.1
224o2dfq2unpzk6hahjr
24 Nov 15
Draft registration statement (amended)
12:00am